Bayer Sells $3.4 Billion Stake in Contraceptives Arm to Apollo
Bloomberg 2026-07-10 06:14:13
Context: Bayer AG has sold a minority stake in its contraceptives business to Apollo Global Management Inc. for $3.4 billion, a deal that will help the German pharmaceutical company improve its capital structure. The transaction, valued at €3 billion, marks a significant move by Bayer to reshape its business portfolio.
Key Facts
- Bayer AG sold a minority stake in its contraceptives business to Apollo Global Management Inc. for €3 billion, which is equivalent to $3.4 billion.
- The funds raised from this deal will be used by Bayer to improve its capital structure, indicating a strategic effort to strengthen its financial position.
- The transaction involves Apollo Global Management Inc., a prominent player in the global investment management industry, acquiring a stake in Bayer's contraceptives business.